A Human Ovarian Carcinoma Murine Xenograft Model Useful for Preclinical Trials

By Elkas J.C.   Baldwin R.L.   Pegram M.   Tseng Y.   Slamon D.   Karlan B.Y.  

Gynecologic Oncology, Vol. 87, Iss. 2, 2002-11 ,pp. : 200-206

Academic Press

Access to resources Recommend Favorite

Preclinical humanized mouse model with ectopic ovarian tissues

By            

Experimental and Therapeutic Medicine, Vol. 8, Iss. 3, 2014-01 ,pp. : 742-746

Spandidos Publications

Access to resources Recommend Favorite

Characterization of the Protein Synthesis Independent TNFalpha Lytic Mechanism in Human Ovarian and Cervical Carcinoma Cell Lines

By Powell C.B.   Scott J.H.   Collins J.L.  

Gynecologic Oncology, Vol. 62, Iss. 1, 1996-07 ,pp. : 42-48

Academic Press

Access to resources Recommend Favorite

Dihydrodiol dehydrogenases regulate the generation of reactive oxygen species and the development of cisplatin resistance in human ovarian carcinoma cells

By Chen Jianli   Adikari Mahesha   Pallai Rajash   Parekh Hemant   Simpkins Henry  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 979-987

Springer Publishing Company

Access to resources Recommend Favorite

Physiologic and Pathologic Drug Resistance in Ovarian Carcinoma: A Hypothesis Based on a Clonal Progression Model

By Pusztai Lajos   Siddik Zahid H.   Mills Gordon B.   Bast Robert C.  

Acta Oncologica, Vol. 37, Iss. 7-8, 1998-12 ,pp. : 629-640

Informa Healthcare

Access to resources Recommend Favorite